C8 N O H13 - CAS号查询

Hexanedioic acid, polymer with 1,6-diisocyanatohexane, 1,2-ethanediol, 1,3-isobenzofurandione, 2,2'-;
Adipic acid, phthalic anhydride, ethylene glycol, diethylene glycol, hexamethylene diisocyanate, N-Methyldiethanolamine polymer, phosphate salt;
hexanedioic acid, polymer with 1,6-diisocyanatohexane, 1,2-ethanediol, 1,3-isob;
enzofurandione, 2,2'-(methylimino)bis[ethanol] and 2,2'-oxybis[ethanol], phosph

无

(C8H12N2O2.C8H4O3.C6H10O4.C5H13NO2.C4H10O3.C2H

详情

供应商

89106-96-7

Atrial natriureticpeptide-21 (rat reduced) (9CI);
Atriopeptin-21(rat reduced);
301: PN: WO0069900 SEQID: 483 unclaimed sequence;
400: PN:US20090175821 SEQID: 483 claimed protein;
L-Serine,L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-

Cytidine-2-14C,2'-deoxy- (7CI,8CI,9CI);
Deoxycytidine-2-14C

C8(14C)H13N3O4

详情

供应商

60893-02-9

r－内啡肽

g-Endorphin (human) (9CI);
a-Endorphin (sheep),16a-L-leucine-;
(61-77)-b-Lipotropic hormone (sheep);
1-17-Human b-endorphin;
121: PN: US20090048431 SEQID: 120 claimedsequence;
153: PN: WO0069900 SEQID: 818 unclaimed sequence;
175: PN: WO0069900SEQID: 840 unclaimed sequence;
184: PN: US20060293232 PAGE: 16 unclaimedsequence;
20: PN: WO2008008805 SEQID: 20 unclaimed protein;
23: PN:WO2007106799 SEQID: 120 unclaimed sequence;
3: PN: WO2009033803 PAGE: 98claimed protein;
61-77-b-Lipotropin (sheep);
665: PN: US20090175821 SEQID: 818 claimed protein;
69: PN: US20090104234 SEQID: 69 unclaimed protein;
Human b-endorphin(1-17);
Human g-endorphin;
L-Leucine,L-tyrosylglycylglycyl-L-phenylalanyl-L-methionyl-L-threonyl-L-seryl-L-a-glutamyl-L-lysyl-L-seryl-L-glutaminyl-L-threonyl-L-prolyl-L-leucyl-L-valyl-L-threonyl-;
Porcine g-endorphin;
g-Endorphin (pig);
g-Endorphin (sheep)

Nocistatin (cattle)(9CI);
Bovinenocistatin;
L-Glutamine, L-threonyl-L-a-glutamyl-L-prolylglycyl-L-leucyl-L-a-glutamyl-L-a-glutamyl-L-valylglycyl-L-a-glutamyl-L-isoleucyl-L-a-glutamyl-L-glutaminyl-L-lysyl-L-glutaminyl-L-leucyl-

Poly(oxy-1,2-ethanediyl),a-[(butylamino)carbonyl]-w-[(1-oxo-2-propenyl)oxy]- (9CI);
NissoCure UM 1

(C2H4O)nC8H13NO3

详情

供应商

101233-12-9

19-37-a-Calcitonin gene-related peptide(human reduced);
a-Calcitonin gene-related peptide(human reduced), 1-de-L-alanine-2-de-L-cysteine-3-de-L-asparticacid-4-de-L-threonine-5-de-L-alanine-6-de-L-threonine-7-de-L-cysteine-8-de-L-valine-9-de-L-threonine-10-de-L-histidine-11-de-L-arginine-12-de-L-leucine-13-de-L-alanine-14-deglycine-15-de-L-leucine-16-de-L-leucine-17-de-L-serine-18-de-L-arginine-;
L-Phenylalaninamide,L-serylglycylglycyl-L-valyl-L-valyl-L-lysyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-valyl-L-prolyl-L-threonyl-L-asparaginyl-L-valylglycyl-L-seryl-L-lysyl-L-alanyl-

PHE-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-ARG-LYS-ASN-GLN;
[ARG14,LYS15]NOCICEPTIN;
[ARG14, LYS15]NOCICEPTIN/ORPHANIN FQ;
[ARG14,LYS15] ORPHANIN FQ;
PHE-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-ARG-LYS-ASN-GLN

蛋白酶A抑制剂6-22酰胺

TYADFIASGRTGRRNAI-NH2;
PROTEIN KINASE INHIBITOR (6-22) AMIDE;
PROTEIN KINASE A INHIBITOR FRAGMENT 6-22 AMIDE;
PROTEIN KINASE A INHIBITOR 6-22 AMIDE;
PKA INHIBITOR FRAGMENT (6-22) AMIDE;
PKA INHIBITOR PEPTIDE;
PKI INHIBITOR (6-22), AMIDE;
PKI (6-22) AMIDE;
PKI 6-22 AMIDE, PKA INHIBITOR

PRION PROTEIN (106-126) (HUMAN) (SCRAMBLED)

H-ASN-GLY-ALA-LYS-ALA-LEU-MET-GLY-GLY-HIS-GLY-ALA-THR-LYS-VAL-MET-VAL-GLY-ALA-ALA-ALA-OH;
PRION PROTEIN (106-126) (HUMAN) (SCRAMBLED);
PRION PROTEIN FRAGMENT 106-126 SCRAMBLED HUMAN;
H-ASN-GLY-ALA-LYS-ALA-LEU-MET-GLY-GLY-HIS-GLY-ALA-THR-LYS-VAL-MET-VAL-GLY-ALA-ALA-ALA-OH;
ASN-GLY-ALA-LYS-ALA-LEU-MET-GLY-GLY-HIS-GLY-ALA-THR-LYS-VAL-MET-VAL-GLY-ALA-ALA-ALA

PRION PROTEIN (106-126) (HUMAN)

H-LYS-THR-ASN-MET-LYS-HIS-MET-ALA-GLY-ALA-ALA-ALA-ALA-GLY-ALA-VAL-VAL-GLY-GLY-LEU-GLY-OH;
H-KTNMKHMAGAAAAGAVVGGLG-OH;
H-KTNMKHMAGAAAAGAWGGLG-OH;
H-LYS-THR-ASN-MET-LYS-HIS-MET-ALA-GLY-ALA-ALA-ALA-ALA-GLY-ALA-VAL-VAL-GLY-GLY-LEU-GLY-OH;
KTNMKHMAGAAAAGAVVGGLG;
LYS-THR-ASN-MET-LYS-HIS-MET-ALA-GLY-ALA-ALA-ALA-ALA-GLY-ALA-VAL-VAL-GLY-GLY-LEU-GLY;
PRION PROTEIN FRAGMENT 106-126 HUMAN;
PRION PEPTIDE (106-126), HUMAN;
PRION PROTEIN (106-126) (HUMAN)

SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER: SSCFGGRIDRIGAQS

atriopeptin I

无

;
(2R,3aR,5aR,5bS,9S,13S,14R,16aS,16bR)-13-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-7,15-dioxo-2,3,3a,4,5,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-octadecahydr o-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-3-O-ethyl-2,4-di-O-methyl-β-L-altropyranoside - (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-13-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyr an-2-yl]oxy}-9-ethyl-4,14-dimethyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-3-O-ethyl-2,4-di-O-methyl-β-L-mannopyranos ide (1:1)

rac Lenalidomide-13C5;
1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline-13C5;
3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione-13C5;
CC-5013-13C5;
rac Lenalidomide-13C5;
Revimid-13C5;
Revlimid-13C;
Revlimid-13C5

无

C8(13C)5H13N3O3

详情

供应商

8003-03-0

APC.;
MIXTUREOFASPIRIN,PHENACETINANDCAFFEINE